ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 74 filers reported holding ANTHERA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 2.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $254,000 | +2.8% | 82,175 | +20.3% | 0.01% | 0.0% |
Q1 2016 | $247,000 | +268.7% | 68,300 | +371.0% | 0.01% | +400.0% |
Q4 2015 | $67,000 | -43.2% | 14,500 | -24.9% | 0.00% | -50.0% |
Q3 2015 | $118,000 | -64.0% | 19,300 | -49.2% | 0.00% | -66.7% |
Q2 2015 | $328,000 | +81.2% | 38,000 | -6.2% | 0.01% | +100.0% |
Q1 2015 | $181,000 | +144.6% | 40,500 | -13.5% | 0.00% | +200.0% |
Q4 2014 | $74,000 | -55.2% | 46,800 | -45.5% | 0.00% | -66.7% |
Q3 2014 | $165,000 | +251.1% | 85,842 | +520.2% | 0.00% | +200.0% |
Q2 2014 | $47,000 | -4.1% | 13,842 | -5.2% | 0.00% | 0.0% |
Q1 2014 | $49,000 | -65.5% | 14,600 | -58.6% | 0.00% | -50.0% |
Q3 2013 | $142,000 | – | 35,264 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ProQuest Associates IV LLC | 1,250,000 | $1,975,000 | 1.00% |
Broadfin Capital, LLC | 3,567,624 | $5,636,000 | 0.24% |
Abingworth LLP | 437,994 | $679,000 | 0.19% |
GREAT POINT PARTNERS LLC | 250,000 | $395,000 | 0.19% |
Rhenman & Partners Asset Management AB | 400,000 | $632,000 | 0.18% |
BVF INC/IL | 559,624 | $884,000 | 0.17% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,691,857 | $2,673,000 | 0.10% |
Perceptive Advisors | 503,156 | $795,000 | 0.07% |
Gruss Capital Management LP | 960,000 | $1,517,000 | 0.04% |
Spark Investment Management LLC | 103,400 | $160,000 | 0.03% |